InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Berger Mark Stanley. Director active across 1 company, notably Genprex, Inc.. Aggregated, 7 filings have been published. History available since 18 February 2023. The latest transaction was disclosed on 27 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Berger Mark Stanley is Chief Medical Officer at Genprex, Inc. He has 7 filings in total. In the 7 recent sampled filings available, the period runs from 2023-02-22 to 2026-02-27, with buy and sell amounts of 0 EUR and 0 EUR, and the most frequent transaction nature is Tax withholding.